Selective immmunotherapy through extracorporeal photochemotherapy: Yesterday, today, and tomorrow

Hematology/Oncology Clinics of North America

Volumn 17, Issue 6, 2003, Pages 1391-1403

  Girardi, Michael ^a   Knobler, Robert ^b   Edelson, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; INTERLEUKIN 12; METHOXSALEN; PSORALEN; RETINOID;

AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; DRUG EFFICACY; DRUG RESPONSE; ELECTRON BEAM; EXTRACORPOREAL PHOTOCHEMOTHERAPY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEPARINIZATION; HUMAN; IMMUNOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; SEZARY SYNDROME; SIDE EFFECT; ULTRAVIOLET A RADIATION;

EID: 0345735912     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(03)00106-0     Document Type: Review

References (92)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303.
2. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy - results of a multicenter trial. Arch Dermatol 1992;128:337-46.
3. DiSpaltro FX, Cottrill C, Cahill C, et al. Extracorporeal photochemotherapy in progressive systemic sclerosis. Int J Dermatol 1993;32:1-5.
4. Zachariae H, Bjerring P, Heickendorff L, Moller B, Wallevik K. Photopheresis and systemic sclerosis. Arch Dermatol 1992;128:1651-3.
5. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Witmer WK, et al. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990;112:303-5.
6. Knobler RM, Graninger W, Lindmaier A, Trautinger F, Smolen J. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum 1992;35:319-24.
7. Knobler RM, Graninger W, Lindmaier A, Trautinger F. Photopheresis for the treatment of lupus erythematosus. Ann NY Acad Sci 1991;636:340-56.
8. Gollnick H, Owsianowski M, Taube K, Orfanos C. Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 1993;28:122-4.
9. Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res 1994;287:48-52.
10. Wilfert H, Honigsmann H, Steiner G, Smolen J, Wolff K. Treatment of psoriatic arthritis by extracorporeal photochemotherapy. Br J Dermatol 1990;122:225-32.
11. Vahlquist C, Larsson M, Emerudh J, Berlin G, Skogh T, Vahlquist A. Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation. Arthritis Rheum 1996;39(9):1519-23.
12. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transpl 1994;14:845-8.
13. Gerber M, Gmeinhart B, Volc-Platzer B, Kalhs P, Greinix H, Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (CP). Bone Marrow Transpl 1997;19:517-9.
14. De Wilde A, DiSpaltro FX, Geller A, Szer IS, Klainer AS, Bisaccia E. Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis. A case report. Arch Dermatol 1992;128:1656-7.
15. Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive cutaneous, chronic graft-versus-host disease. Transplantation 1995;59:149-51.
16. Vonderheid EC, Kang CA, Kadin M, Bigler RD, Griffin TD, Rogers TJ. Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations. J Am Acad Dermatol 1990;23:703-12.
17. Zachariae H, Bjerring P, Brodthagen U, Sogaard H. Photopheresis in the red man or pre-Sézary syndrome. Dermatology 1995;190:132-5.
18. Randazzo JP, DiSpaltro FX, Cottrill C, Klainer AS, Steere AC, Bisaccia E. Successful treatment of a patient with chronic Lyme arthritis with extracorporeal photochemotherapy. J Am Acad Dermatol 1994;30:908-10.
19. Malawista SE, Trock DH, Edelson RL. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy: a pilot study. Arthritis Rheum 1991;34:646-54.
20. Licht-Mbalyohere A, et al. Extracorporeal photochemotherapy of therapy-refractory cases of systemic lupus erythematosus with urticarial vasculitis and pemphigus foliaceus. Eur J Dermatol 1996;6:106-9.
21. Liang G, Nahass G, Kerdel FA. Pemphigus vulgaris treated with photopheresis. J Am Acad Dermatol 1992;26:779-80.
22. Berkson M, Lazarus GS, Uberti-Benz M, Rook AH. Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedema. J Am Acad Dermatol 1991;25:724.
23. Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992;53:808-15.
24. Costanzo-Nordin MR, Hubbell EA, O'Sullivan EJ, Johnson MR, Mullen GM, Heroux AL, et al. Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Circulation 1992;86:242-50.
25. Hilliquin P, Andreu G, Heshmati F, Menkes CJ. Treatment of refractory rheumatoid arthritis by extracorporeal photochemotherapy. Rheumatol Rev 1993;60:125-30.
26. Rose EA, Barr ML, Xu H, Pepino P, Murphy MP, McGovern MA, et al. Photochemotherapy in human heart transplant recipients at high risk for fatal rejection. J Heart Lung Transpl 1992;11:746-50.
27. Sunder-Plassman G, Druml W, Steininger R, Honigsmann H, Knobler R. Renal allograft rejection controlled by photopheresis. Lancet 1995;346:506.
28. Wolfe JT, Tomaszewski JE, Grossman RA, Gottlieb SL, Naji A, Brayman KL, et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apheresis 1996;11:36-41.
29. Slovis BS, Loyd JE, King Jr LE. Photopheresis for chronic rejection of lung allografts. N Engl J Med 1995;332:962.
30. Andreu G, Achkar A, Couetil JP, Guillemain R, Heshmati F, Amrein C, et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995;14(4):793-6.
31. Heald PW, Perez MI, Christensen I, Dobbs N, McKiernan G, Edelson R. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital Experience. Yale J Biol Med 1989;62:629-38.
32. Arrnus S, Keyes B, Cahill C, Berger C, Crater D, Scarborough D, et al. Photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1990;23:898-902.
33. Zic J, Arzubiaga C, Salhany KE, Parker RA, Wilson D, Stricklin GP, et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Derrnatol 1992;27:729-36.
34. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996;35:573-9.
35. Dall'Amico R, Zacchello G, Heald P. Applicazione della fotoferesis nella terapia di malattie oncologiche ed autiommuni. [The application of photopheresis in the therapy of cancerous and autoimmune disease]. Recenti Prog Med 1991;82(5):294-9 [in Italian].
36. Koh HK, Davis BE, Meola T, Lim HW. Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T-cell lymphoma (CTCL). Soc Invest Dermatol 1994;2(4):260.
37. Prinz B, Behrens W, Holzle E, Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: the Düsseldoff and Munich experience. Arch Dermatol Res 1995;287: 1-6.
38. Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, et al. Long term follow-up with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996;356:935-45.
39. Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: a 10 year experience at a single institution. J Am Acad Dermatol 1996;35:946-57.
40. Owsianowski M, Garbe C, Ramaker J, Orfanos CE, Gollnick H. Therapeutische erfahrungen mit der extracorporalen photopherese. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases.] Hautarzt 1996;47:114-23.
41. Konstantinow A, Balda BR. Treatment of cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Eur Acad Dermatol Venerol 1997;9:111-7.
42. Russell-Jones R, Fraser-Andrews E, Spittle M, Whittaker S. Extracorporeal photopheresis in Sézary syndrome. Lancet 1997;350:886.
43. Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, et al. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998;38:207-20.
44. Zouboulis CC, Schmuth M, Doepfmer S, Dippel E, Orfanos CE. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes. Dermatology 1998;196:305-8.
45. Jiang SB, Dietz SB, Kim M, Lim HW. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience. Photodermatol Photoimmunol Photomed 1999;15:161-5.
46. Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. J Am Acad Dermatol 2000;43:263-71.
47. Crovetti G, Carabelli A, Berti E, Guizzardi M, Fossati S, De Filippo C, et al. Photopheresis in cutaneous T-cell lymphoma: five-year experience. Int J Artif Organs 2000;23(1):55-62.
48. Wollina U, Liebold K, Kaatz M, Looks A, Stuhlert A, Lange D. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy. Oncol Rep 2000;7:1197-201.
49. Knobler E, Warrnuth I, Cocco C, Miller B, Mackay J. Extracorporeal photochemotherapy- the Columbia Presbyterian experience. Photodermatol Photoimmunol Photomed 2002;18:232-7.
50. Stevens SR, Baron ED, Masten S, Cooper KD. Circulating CD4+CD7-lymphocyte burden and rapidity of response. Arch Dermatol 2002;138:1347-50.
51. Suchin KR, Cucchiara AJ, Gottleib SL, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol 2002;138(8):1054-60.
52. Fraser-Andrews E, Seed P, Whittaker S, Russell-Jones R. Extracorporeal photopheresis in Sézary syndrome. Arch Dermatol 1998;134:1001-5.
53. Russell-Jones R. Extracorporeal photopheresis in cutaneous T-cell lymphoma: inconsistent data underline the need for randomized studies. Br J Dermatol 2000;142:16-21.
54. Rook AH, Suchin KR, Kao DM, Yoo EK, Macey WH, DeNardo BJ, et al. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999;4:85-90.
55. Knobler RM, Edelson RL. Cutaneous T-cell lymphoma. Med Clin North Am 1986;70:109-38.
56. Knobler RM. Photopheresis - extracorporeal irradiation of 8-MOP containing blood - a new therapeutic modality. Blood 1987;54:247-50.
57. Ingen-Housz-Oro S, Bussel A, Flageul B, et al. Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique. Transfus Apheresis Sci 2003;28:35-42.
58. Heald P, Knobler R, LaRoche L. Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma. Dermatol Clin 1994;12:443-9.
59. Knobler R. Photopheresis and the red-man syndrome. Dermatology 1995;190:392-7.
60. Berger CL, Perez M, Laroche L, Edelson R. Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol 1990;94:52-7.
61. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996;107:392-7.
62. Edelson R. Light activated drugs. Sci Am 1988;259:68-75.
63. Gasparro FP, Song J, Knobler RM, Edelson RL. Quantitation of psoralen photoadducts in DNA isolated from lymphocytes treated with 8-methoxypsoralen and ultraviolet a radiation (extracorporeal photopheresis). Curr Probl Dermatol 1986;15:67-84.
64. Gasparro FP, Dall'Amico R, O'Malley M, Heald PW, Edelson RL. Cell membrane DNA: a new target for psoralen photoadduct formation. Phochem Photobiol 1990;52:315-21.
65. Perez M, Edelson R, Laroche L, Berger C. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol 1989;92:669-76.
66. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH. Extracorporeal photo-chemotherapy induces the production of tumor necrosis factor-α by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992;96:686-92.
67. Girardi M, Herreid P, Tigelaar R. Specific suppression of lupus-like graft versus host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol 1995;104:177-82.
68. Berger CL, Longley J, Hanlon D, et al. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma. Ann N Y Acad Sci 2001;941:106-22.
69. Schmitt IM, Moor AC, Patrignelli R, Chimenti S, Beijersbergen van Henegouwen GM, Edelson RL, et al. Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation. Tissue Antigens 1995;46:45-9.
70. Knobler RM, Trautinger F, Graninger W, Macheiner W, Gruenwald C, Neumann R, et al. Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 1993;28:580-4.
71. Sumpio BE, Phan SM, Gasparro FP, Deckelbaum LI. Control of smooth muscle cell proliferation by psoralen photochemotherapy. J Vasc Surg 1993;17:1010-6.
72. Trautinger F, Knobler RM, Macheiner W, Grunwald C, Micksche M. Release of oxygen-free radicals by neutrophils is reduced by photopheresis. Ann N Y Acad Sci 1991;636:383-5.
73. van Iperen HP, Beijersbergen van Henegouwen GM. Animal model for extracorporeal photochemotherapy based on contact hypersensitivity. J Photochem Photobiol Biol 1992;15:361-6.
74. Yamane Y, Lobo FM, John LA, Edelson RL, Perez MI. Suppression of anti-skin-allograft response by photodamaged effector cells - the modulating effects of prednisone and cyclophosphamide. Transplantation 1992;54:119-24.
75. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996;107:392-7.
76. Hanlon DJ, Berger CL, Edelson RL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int J Cancer 1998;76:70-5.
77. Berger CL, Longley BJ, Imaeda S, Christensen I, Heald P, Edelson RL. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor. Int J Cancer 1998;76:304-11.
78. Berger CL, Xu AL, Hanlon D, et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 2001;91:438-47.
79. Rook AH, Prystowsky MB, Cassin M, Boufal M, Lessin SR. Combined therapy for sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Arch Dermatol 1991;127:1535-40.
80. Cohen J, Lessin S, Vowels B, Benoit B, Witmer W, Rook A. The sign of Leser-Trelat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa. Arch Dermatol 1993;129: 1213-5.
81. Fimiani M, Rubegni P, De Aloe G, Andreassi L. Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1999;41:502-3.
82. Vonderheid EC, Bigler RD, Greenberg AS, Neukum SJ, Micaily B. Extracorporeal photopheresis and recombination interferon alfa 2b in Sézary syndrome: use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol 1994;17:255-63.
83. Olsen EA, Bunn PA. Interferon in the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin N Am 1995;9:1089-107.
84. Jumbou O, N'Guyen JM, Tessier MH, Legoux B, Dreno B. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa. Br J Dermatol 1999;140: 427-31.
85. Haley HR, Davis DA, Sams WM. Durable loss of malignant T-cell clone in a stage IV cutaneous T-cell lymphomas patient treated with high-doses interferon and photopheresis. J Am Acad Dermatol 1999;41:880-3.
86. Dippel E, Schrag H, Goerdt S, Orfanos CE. Extracorporeal photopheresis and Interferon-α in advanced cutaneous T-cell lymphoma. Lancet 1997;350:32-3.
87. Zackheim HS. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma. J Am Acad Dermatol 2000;42:1087-8.
88. Fritz TM, Kleinhans M, Nestle FO, Burg G, Dummer R. Combination treatment with extracorporeal photopheresis interferon alfa and interleukin-2 in a patient with the Sézary syndrome. Br Ass Dermatol 1999;140:1144-7.
89. Rook AH, Gottlieb SL, Wolfe JT, Vowels BR, Sood SS, Niu Z, et al. Pathogenesis of cutaneous T-cell lymphoma: implication for the use of recombinant cytokines and photopheresis. Clin Exp Immunol 1997;107(Suppl. 1):16-20.
90. Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DM, Sherman ML, et al. Interleukin 12 induces lesion regression and cytotoxic T cell responses in cutaneous T cell lymphomas. Blood 1999;94:902-8.
91. Wilson LD, Licata AL, Braverman IM, Edelson RL, Heald PW, Feldman AM, et al. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. Int J Radiation Oncol Biol Phys 1995;32(4):987-95.
92. Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000;43:54-60.